The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells

Figure 6

Annexin V/PI double-staining assay. Control or COMMD1 siRNA cells were treated with CIGB-552 (25 μM) for 24 h and 48 h and apoptosis was examined with flow cytometry after Annexin V/propidium iodine double staining. The data shown are representative of three independent experiments with similar findings.